206
Participants
Start Date
June 8, 2017
Primary Completion Date
August 4, 2027
Study Completion Date
August 13, 2027
everolimus
everolimus, 2mg dispersible tablets
Novartis Investigative Site, Brussels
Novartis Investigative Site, Budapest
Novartis Investigative Site, Brussels
Novartis Investigative Site, Randwick
Novartis Investigative Site, Leuven
Novartis Investigative Site, Nedlands
Novartis Investigative Site, Ghent
Novartis Investigative Site, Taipei
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Marseille
Childrens Hospital of Philadelphia, Philadelphia
Novartis Investigative Site, Donostia / San Sebastian
Novartis Investigative Site, Pavia
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Bologna
Novartis Investigative Site, Seville
Novartis Investigative Site, Guadalajara
Novartis Investigative Site, Valencia
Novartis Investigative Site, Siena
Minnesota Epilepsy Group, Saint Paul
Novartis Investigative Site, Lille
University of Chicago Medical Center, Chicago
Novartis Investigative Site, Strasbourg
Novartis Investigative Site, Bron
Novartis Investigative Site, Bari
Novartis Investigative Site, Tainan City
Texas Scottish Rite Hos for Child, Dallas
Texas Childrens Hospital, Houston
University of Colorado School of Medicine, Aurora
Novartis Investigative Site, Amiens
Novartis Investigative Site, Kaohsiung City
TGen APNNA, Phoenix
Rady Children s Hospital, San Diego
UCSF Benioff Children s Hospital, Oakland
Oregon Health Sciences University, Portland
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Voronezh
Novartis Investigative Site, Samara
Novartis Investigative Site, Santiago de Cali
David Geffen School of Medicine at UCLA, Los Angeles
Connecticut Childrens Medical Cntr, Hartford
Atlantic Health Systems, Morristown
Cinn Children Hosp Medical Center, Cincinnati
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Roma
Novartis Investigative Site, Okayama
Novartis Investigative Site, Suita
Novartis Investigative Site, Shizuoka
Novartis Investigative Site, Osaka
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Ankara
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Buckinghamshire
Novartis Investigative Site, Cambridge
Novartis Investigative Site, Liverpool
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Sheffield
Novartis Investigative Site, York
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY